Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 30, 2001Journal of Advanced Nursing

Timing of quality of life (QoL) assessments as a source of error in oncological trials

View Full Paper
Ask AI
Bookmark
Share

Authors

LHLiisa Hakamies‐BlomqvistUniversity of HelsinkiMLMinna‐Liisa LuomaFinnish Institute for Health and WelfareJSJ SjöströmHelsinki University Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hakamies‐Blomqvist et al. (2001) studied this question.

synapsesocial.com/papers/6a7255d535aa2c282ce3345ahttps://doi.org/10.1046/j.1365-2648.2001.01903.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Completion rates in health-related quality-of-life assessment: approach of the National Cancer Institute of Canada Clinical Trials Group1998 · 36 citations
  2. 2Missing quality of life data in cancer clinical trials: serious problems and challenges1998 · 165 citations
  3. 3Quality of life as an endpoint in EORTC clinical trials1998 · 45 citations
  4. 4The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology1993 · 16,271 citations